New dye technique could improve liver cancer surgery outcomes

NCT ID NCT07295275

Recruiting now Disease control Sponsor: West China Hospital Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated May 24, 2026 · Updated 18 times

Summary

This study looks at 200 adults with liver cancer to compare two ways of using a special dye during surgery. The dye helps surgeons see and remove only the diseased part of the liver. One method injects the dye through an artery, the other through a vein. The goal is to see which approach leads to fewer cancer recurrences and complications.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Beijing Tsinghua Changgung Hospital
RECRUITING

Beijing, Beijing Municipality, China

Contact Phone: •••-•••-••••
West China Hospital
RECRUITING

Chengdu, Sichuan, 610041, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
Xuzhou Central Hospital
RECRUITING

Xuzhou, Jiangsu, China

Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.

LIVER CANCER